Industry panel: avoid one-size-fits-all approach to OTC derivatives
A panel of industry experts on June 9 urged the US House Financial Services Subcommittee to steer clear of broad, one-size-fits-all regulation for over-the-counter derivatives.
Testifying before the subcommittee, Timothy Murphy, foreign currency risk manager at consumer products company 3M, underlined the importance of OTC derivatives to companies looking to manage their exposure to foreign exchange, interest rates and commodities, and voiced "strong concerns" about the impact regulation could have on the market. He emphasised that not all OTC derivatives were involved in triggering or exacerbating the financial crisis, and therefore "not all OTC derivatives should be treated the same".
Murphy - whose views were echoed by Don Thompson, managing director and associate general counsel at JP Morgan - opposed any mandate to transfer all derivatives to clearing houses or exchanges. Thompson warned the standardisation of OTC derivatives - which moves towards clearing and exchanges would require - would "limit [companies'] ability to manage risk". In particular, companies would be required to dynamically post collateral - potentially increasing operating costs - and would not qualify for hedge accounting, leaving them open to market volatility.
Moreover, most panel members were keen to stress the benefits of companies being able to have OTC derivatives tailored to their needs. "Customisation does not necessarily mean complexity," explained Thompson.
Robert Pickel, chief executive of the International Swaps and Derivatives Association, underlined the work Isda and the industry had already undertaken with respect to standardisation. Pickel pledged continued support to regulators in helping develop further regulation for the OTC derivatives market, while underlining the market's central role in the financial services industry.
Meanwhile, Christian Johnson, professor at the University of Utah School of Law, warned against overly harsh regulation, as the OTC derivatives market is a "truly global industry that will move towards wherever it is easiest to trade".
In opening remarks, the majority of the subcommittee acknowledged the importance of OTC derivatives to risk management practices for US companies. Republican congressman Tom Price said: "When used appropriately, [derivatives] can be a very effective risk management tool." Price also accepted the particular importance of OTC derivatives and cautioned against implementing one-size-fits-all regulatory measures.
This positive view of OTC derivatives was not shared by all subcommittee members, however. "At best these derivatives are insurance; at worse they are a bet at the casino," said Democrat congressman Brad Sherman.
See also: Geithner outlines regulations for over-the-counter market
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
More on Risk management
Buy side would welcome more guidance on managing margin calls
FSB report calls for regulators to review existing standards for non-bank liquidity management
Japanese megabanks shun internal models as FRTB bites
Isda AGM: All in-scope banks opt for standardised approach to market risk; Nomura eyes IMA in 2025
Benchmark switch leaves hedging headache for Philippine banks
If interest rates are cut before new benchmark docs are ready, banks face possible NII squeeze
Op risk data: Tech glitch gives customers unlimited funds
Also: Payback for slow Paycheck Protection payouts; SEC hits out at AI washing. Data by ORX News
The American way: a stress-test substitute for Basel’s IRRBB?
Bankers divided over new CCAR scenario designed to bridge supervisory gap exposed by SVB failure
Industry warns CFTC against rushing to regulate AI for trading
Vote on workplan pulled amid calls to avoid duplicating rules from other regulatory agencies
Top 10 op risks: change brings challenges as banks splash the cash
Higher interest margins and a trend toward insourcing drive major tech projects
Top 10 op risks: deepfakes drive rise in fraud fears
External fraud re-enters top 10 as artificial intelligence provides new tools for criminals
Most read
- Top 10 operational risks for 2024
- Top 10 op risks: third parties stoke cyber risk
- Japanese megabanks shun internal models as FRTB bites